Recombinant Anti-Human MUC1 Antibody (Non-glycosylated) (CAT#: Gly-121LC)

1. Q 1: What is the significance of the Anti-Human MUC1 Antibody in research?

   A: This Recombinant Anti-Human MUC1 Antibody is valuable in studying MUC1, a mucin protein that is often overexpressed in epithelial cancers such as breast and ovarian cancers. It helps in understanding the role of MUC1 in tumor progression, metastasis, and therapy resistance, providing insights that are crucial for developing targeted cancer therapies.

2. Q 2: How does the non-glycosylated form of the antibody enhance research applications?

   A: The non-glycosylated variant of the Anti-MUC1 Antibody allows for more accurate studies of protein interactions that may be affected by glycosylation processes. This form provides more consistent results, eliminating potential variations introduced by glycan structures, which is critical for understanding the core functions and interactions of MUC1.

3. Q 3: How does this antibody aid in ovarian cancer research?

   A: The increased affinity of the non-glycosylated form enhances its utility in ovarian cancer research by providing precise detection of MUC1. Its role as a biomarker facilitates the tracking of disease progression and the evaluation of therapeutic response, aiding in better clinical outcomes.

View the frequently asked questions answered by Creative Biolabs Support.